- Our Work
- Kilas Balik
- Pencapaian Kami
- Dollars to Results
- Partnership Opportunities
- Kesempatan untuk Kemitraan
REDUCING PREVENTABLE DEATHS, ESPECIALLY IN WOMEN AND CHILDREN
Indonesia’s newborn mortality rate has not declined in 10 years, with over 88,000 newborn deaths annually, and maternal mortality rising. The country is not expected to achieve its 2015 Millennium Development Goal targets in either area. USAID’s maternal and child health program helps mothers at the moment of delivery when they need it the most. Through appropriate referral, access to social health insurance, and improved care at health facilities, mothers and newborns with complications can be saved. USAID’s program works with government at every level, the private sector, professional associations, civil society organizations (CSOs), as well as leading Indonesian organizations Muhammadiyah and Budi Kemuliaan Health Foundation to build sustainable local responses and health systems by mentoring health practitioners on improved management and response to complications during and after childbirth.
USAID supports the government’s hospital quality improvement program, helping nine top-level public hospitals to achieve international accreditation standards, and supporting a stronger national hospital accreditation system. USAID works with UNICEF in Eastern Indonesia to improve maternal and newborn care and prevent malaria in pregnancy. USAID co-chairs the Family Planning 2020 country engagement working group to advocate for an improved national family planning program, supports polio surveillance, and supports capacity building for data analysis of the Indonesia Demographic and Health Survey.
CONTROLLING INFECTIOUS DISEASE
Tuberculosis: Every year, there are about 500,000 new tuberculosis (TB) cases and approximately 65,000 TB-related deaths in Indonesia. Cases of multi-drug resistant TB are on the rise. USAID partners with Indonesia’s National TB Program to improve case detection and treatment, to build the network, capacity, and quality of laboratory services, to expand the number of multi-drug resistant TB treatment facilities, and guarantee the quality and supply of drugs. Our projects strengthen community support for TB patients by combatting the social stigma they face. USAID also provides technical assistance to Indonesian drug manufacturers to obtain World Health Organization pre-qualification for domestic production of TB drugs, and introduced the new GeneXpert technology that diagnoses multi-drug resistant TB in hours instead of months.
HIV/AIDS: Indonesia is experiencing a rapidly growing HIV epidemic, with an estimated 480,000 people living with HIV/AIDS. The epidemic is concentrated among at-risk groups, including injecting drug users, sex workers and their clients, men who have sex with men, and transgender persons. The exception is Papua, where the prevalence rate is 15 times higher than the national rate. USAID provides technical assistance to the Ministry of Health and the National AIDS Commission to accelerate the use of effective prevention measures, and to strengthen capacity to gather and use strategic information to respond to the epidemic. USAID also helps CSOs increase organizational capacity and expand reach of HIV/AIDS health services. USAID contributes to the National AIDS Commission’s Indonesian Partnership Fund, which funds the national HIV response.
Emerging Pandemic Threats and Avian Influenza: Indonesia is considered a hotspot for emerging diseases due to its climate, biodiversity, the close interaction of humans with animals, deforestation, and land-use changes. Additionally, Indonesia has the highest number of human cases and case fatality rate from highly pathogenic avian influenza virus (H5N1) in the world. USAID supports the GOI to identify risks and respond to potentially dangerous pathogens in animals before they become threats to human health, including support for key laboratories for globally important research and surveillance. USAID supports prevention and control activities of known and emerging disease threats by facilitating outbreak responses, preparing port health offices, raising public awareness, improving biosecurity at farms and markets, and supporting research on transmission, and clinical practices.
Neglected Tropical Diseases: More than 125 million people are estimated at risk for lymphatic filariasis in Indonesia, and intestinal worms are endemic nationally. USAID supports the GOI to map the burden of disease, develop national strategies for the elimination of these diseases, and conduct community-based campaigns providing preventive chemotherapy to 16 million people in 37 districts across Indonesia.
INCREASING ACCESS TO SAFE WATER AND SANITATION
USAID supports the GOI’s strategy to increase access to safe drinking water and improved sanitation, with an emphasis on reaching poor people in urban areas to reduce diarrhea and other waterborne illnesses. USAID helps to improve governance within public and private water utilities and increase demand and access to basic sanitation in communities. Our projects partner with local banks to provide microfinance loans to poor families in order to pay for water installation fees, one of the major barriers to water access. Poor communities have decreased their per unit cost of water by 32% through our programs.
Last updated: March 24, 2015